Compare BMRA & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRA | RVYL |
|---|---|---|
| Founded | 1971 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 9.3M |
| IPO Year | 1995 | 2008 |
| Metric | BMRA | RVYL |
|---|---|---|
| Price | $2.05 | $5.74 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.8K | 9.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.34 |
| EPS | ★ N/A | N/A |
| Revenue | $5,311,000.00 | ★ $55,998,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $297.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.40 | $0.14 |
| 52 Week High | $4.60 | $8.55 |
| Indicator | BMRA | RVYL |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 53.54 |
| Support Level | $1.87 | $5.34 |
| Resistance Level | $2.23 | $6.10 |
| Average True Range (ATR) | 0.13 | 0.35 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 64.25 | 52.04 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.